Name | B-9430 TRIFLUOROACETATE SALT |
---|---|
Synonyms |
Glycinamide, N5-(diaminomethylene)-D-ornithyl-N5-(diaminomethylene)-L-ornithyl-L-prolyl-(4R)-4-hydroxy-L-prolyl-N-[(1S)-2-[[(1S)-2-[[(1R)-2-[(2S,3aS,7aS)-2-[[[(1S)-1-carboxy-4-[(diaminomethylene)a ; mino]butyl]amino]carbonyl]octahydro-1H-indol-1-yl]-1-(2,3-dihydro-1H-inden-2-yl)-2-oxoethyl]amino]-1-(hydroxymethyl)-2-oxoethyl]amino]-1-(2,3-dihydro-1H-inden-2-yl)-2-oxoethyl]-
N5-(Diaminomethylene)-D-ornithyl-N5-(diaminomethylene)-L-ornithyl-L-prolyl-(4R)-4-hydroxy-L-prolyl-N-[(1S)-2-{[(2S)-1-{[(1R)-2-[(2S,3aS,7aS)-2-({(1S)-1-carboxy-4-[(diaminomethylene)amino]butyl}car bamoyl)octahydro-1H-indol-1-yl]-1-(2,3-dihydro-1H-inden-2-yl)-2-oxoethyl]amino}-3-hydroxy-1-oxo-2-propanyl]amino}-1-(2,3-dihydro-1H-inden-2-yl)-2-oxoethyl]glycinamide |
Description | B 9430 is a potent bradykinin B1/B2 receptor antagonist[1]. |
---|---|
Related Catalog | |
Target |
Bradykinin B1 Receptor (B1R) Bradykinin B2 Receptor (B2R) |
In Vivo | B 9430 decreases the number of leukocytes attached to the endothelial surface and alleviate cerebral microcirculation in gerbil after global cerebral ischemia[1]. |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C64H95N19O13 |
Molecular Weight | 1338.559 |
Exact Mass | 1337.735718 |
LogP | 0.12 |
Appearance | Solid |
Index of Refraction | 1.740 |
Storage condition | ?20°C |